Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PROF | IKT | HRTX | ||
| Company | Profound Medical Corp | Inhibikase Therapeutics Inc | Heron Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.81 | 1.9100 | 1.2900 | ||
| High | 7.01 | 1.9900 | 1.3000 | ||
| Low | 6.66 | 1.8900 | 1.2000 | ||
| Latest | 6.70 | 1.9400 | 1.2200 | ||
| Change | -0.16 | +0.0300 | -0.0500 | ||
| % Change | -2.33% | +1.57% | -3.94% | ||
| Volume | 91,200 | 451,800 | 2,118,600 | ||
| 20-Day Average Volume | 86,665 | 991,140 | 2,123,590 | ||
| Previous Close | 6.86 | 1.9100 | 1.2700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.62 | 1.8050 | 1.0297 | ||
| 20-Day Raw Stochastic | 61.87% | 86.11% | 85.05% | ||
| 20-Day Relative Strength | 51.97 | 56.45 | 63.47 | ||
| Weighted Alpha | +62.36 | +4.47 | -33.47 | ||
| Today's Opinion | 40% Buy | 88% Buy | 8% Sell | ||
| Previous Opinion | 40% Buy | 80% Buy | 8% Buy | ||
| Last Month's Opinion | 8% Sell | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.74% since 04/27/26 | +2.65% since 04/27/26 | +2.52% since 04/27/26 | ||
| Low | 6.50 on 04/29/26 | 1.8300 on 05/01/26 | 1.1600 on 04/30/26 | ||
| High | 7.09 on 05/01/26 | 1.9900 on 05/04/26 | 1.3000 on 05/04/26 | ||
| 1-Month | |||||
| %Chg | +4.20% since 04/02/26 | +7.78% since 04/02/26 | +52.65% since 04/02/26 | ||
| Low | 5.84 on 04/13/26 | 1.6300 on 04/21/26 | 0.7649 on 04/07/26 | ||
| High | 7.23 on 04/20/26 | 1.9900 on 05/04/26 | 1.3000 on 05/04/26 | ||
| 3-Month | |||||
| %Chg | -1.76% since 02/04/26 | +24.36% since 02/04/26 | -7.58% since 02/04/26 | ||
| Low | 4.80 on 03/09/26 | 1.5300 on 02/05/26 | 0.7362 on 03/30/26 | ||
| High | 7.99 on 02/27/26 | 2.2600 on 02/25/26 | 1.3300 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +13.75% since 11/04/25 | +22.01% since 11/04/25 | +7.02% since 11/04/25 | ||
| Low | 4.80 on 03/09/26 | 1.3900 on 11/07/25 | 0.7362 on 03/30/26 | ||
| High | 8.95 on 01/13/26 | 2.2600 on 02/25/26 | 1.5750 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 249,279 | 252,240 | 239,572 | ||
| Shares Outstanding, K | 36,338 | 132,063 | 188,639 | ||
| Annual Sales | 16,100,000 | 0 | 154,900,000 | ||
| Annual Net Income | -42,570,000 | -48,260,000 | -20,200,000 | ||
| Last Quarter Sales | 5,980,000 | 0 | 40,590,000 | ||
| Last Quarter Net Income | -8,170,000 | -12,730,000 | -2,950,000 | ||
| 60-Month Beta | 0.73 | 0.96 | 1.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 03/05/26 | -0.09 on 03/26/26 | -0.02 on 02/26/26 | ||
| Earnings Date | 05/07/26 | 05/13/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||